At-Home Drug of Abuse (DOA) Testing Market Report

Global and China At-Home Drug of Abuse (DOA) Testing Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 08, 2022
  • PAGES：173
  • REPORT CODE：GMM1447059
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.

    This report elaborates on the current development of the At-Home Drug of Abuse (DOA) Testing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • UCP Biosciences

    • Orient New Life Medical

    • Express Diagnostics Int’l

    • Assure Tech (Hangzhou)

    • Psychemedics Corporation

    • Confirm BioSciences

    • Phamatech

    • Quest Products

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Test Cups

    • Test Dip Cards

    • Test Strips

    • Others

    Application:

    • Urine

    • Saliva

    • Hair

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 At-Home Drug of Abuse (DOA) Testing Industry Overview

      • 1.1.1 At-Home Drug of Abuse (DOA) Testing Market Scope and Market Segments

      • 1.1.2 At-Home Drug of Abuse (DOA) Testing Industry Characteristics

      • 1.1.3 Global and China At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China At-Home Drug of Abuse (DOA) Testing Production Value and Growth Rate (2017-2028)

    • 1.2 Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Test Cups

      • 1.2.2 Test Dip Cards

      • 1.2.3 Test Strips

      • 1.2.4 Others

    • 1.3 Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Urine

      • 1.3.2 Saliva

      • 1.3.3 Hair

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global At-Home Drug of Abuse (DOA) Testing Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 At-Home Drug of Abuse (DOA) Testing Industry Porter's Five Forces Model Analysis

      • 2.2.3 At-Home Drug of Abuse (DOA) Testing Industry PEST Analysis

    • 2.3 At-Home Drug of Abuse (DOA) Testing Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 At-Home Drug of Abuse (DOA) Testing Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on At-Home Drug of Abuse (DOA) Testing Industry

    Chapter 3 Global and China At-Home Drug of Abuse (DOA) Testing Market, by Manufacturer

    • 3.1 Global and China At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China At-Home Drug of Abuse (DOA) Testing Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China At-Home Drug of Abuse (DOA) Testing Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China At-Home Drug of Abuse (DOA) Testing Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China At-Home Drug of Abuse (DOA) Testing Market Top 3 Players

    Chapter 4 Global and China At-Home Drug of Abuse (DOA) Testing Market, by Type (2017-2028)

    • 4.1 At-Home Drug of Abuse (DOA) Testing Market Trend, by Type

    • 4.2 Global At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global At-Home Drug of Abuse (DOA) Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global At-Home Drug of Abuse (DOA) Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global At-Home Drug of Abuse (DOA) Testing Price Trend, by Type (2017-2028)

    • 4.3 China At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China At-Home Drug of Abuse (DOA) Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China At-Home Drug of Abuse (DOA) Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China At-Home Drug of Abuse (DOA) Testing Price Trend, by Type (2017-2028)

    Chapter 5 Global and China At-Home Drug of Abuse (DOA) Testing Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global At-Home Drug of Abuse (DOA) Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global At-Home Drug of Abuse (DOA) Testing Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China At-Home Drug of Abuse (DOA) Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China At-Home Drug of Abuse (DOA) Testing Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America At-Home Drug of Abuse (DOA) Testing Market Analysis

    • 7.1 North America At-Home Drug of Abuse (DOA) Testing Market, by Type

    • 7.2 North America At-Home Drug of Abuse (DOA) Testing Market, by Application

    • 7.3 North America At-Home Drug of Abuse (DOA) Testing Market Analysis and Forecast, by Country

      • 7.3.1 United States At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe At-Home Drug of Abuse (DOA) Testing Market Analysis

    • 8.1 Europe At-Home Drug of Abuse (DOA) Testing Market, by Type

    • 8.2 Europe At-Home Drug of Abuse (DOA) Testing Market, by Application

    • 8.3 Europe At-Home Drug of Abuse (DOA) Testing Market Analysis and Forecast, by Country

      • 8.3.1 Germany At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC At-Home Drug of Abuse (DOA) Testing Market Analysis

    • 9.1 APAC At-Home Drug of Abuse (DOA) Testing Market, by Type

    • 9.2 APAC At-Home Drug of Abuse (DOA) Testing Market, by Application

    • 9.3 APAC At-Home Drug of Abuse (DOA) Testing Market Analysis and Forecast, by Country

      • 9.3.1 China At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Analysis

    • 10.1 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market, by Type

    • 10.2 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market, by Application

    • 10.3 Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina At-Home Drug of Abuse (DOA) Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China At-Home Drug of Abuse (DOA) Testing Company Profiles

      • 11.1 UCP Biosciences

        • 11.1.1 UCP Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Orient New Life Medical

        • 11.2.1 Orient New Life Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Express Diagnostics Int’l

        • 11.3.1 Express Diagnostics Int’l Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Assure Tech (Hangzhou)

        • 11.4.1 Assure Tech (Hangzhou) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Psychemedics Corporation

        • 11.5.1 Psychemedics Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Confirm BioSciences

        • 11.6.1 Confirm BioSciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Phamatech

        • 11.7.1 Phamatech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Phamatech At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Quest Products

        • 11.8.1 Quest Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Quest Products At-Home Drug of Abuse (DOA) Testing Product Profiles, Application and Specification

        • 11.8.3 Quest Products At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 At-Home Drug of Abuse (DOA) Testing Industry Investment Prospect and Risk Assessment

    • 12.1 At-Home Drug of Abuse (DOA) Testing Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 At-Home Drug of Abuse (DOA) Testing Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Production Value and Growth Rate (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Production Value and Growth Rate (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Test Cups (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Test Dip Cards (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Test Strips (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Others (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Urine (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Saliva (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Hair (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Market Size and Growth Rate of Others (2017-2028)

    • Figure North America At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China At-Home Drug of Abuse (DOA) Testing Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China At-Home Drug of Abuse (DOA) Testing Sales Value, by Manufacturer (2021&2022)

    • Table Global and China At-Home Drug of Abuse (DOA) Testing Market Share, by Manufacturer (2021&2022)

    • Figure Global and China At-Home Drug of Abuse (DOA) Testing Market Share, by Manufacturer in 2021

    • Figure Global and China At-Home Drug of Abuse (DOA) Testing Market Share, by Manufacturer in 2022

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Value, by Type (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Type (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Price Trend, by Type (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Value, by Type (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Type (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Price Trend, by Type (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Value, by Application (2017-2028)

    • Table Global At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Application (2017-2028)

    • Figure Global At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Application (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Value, by Application (2017-2028)

    • Table China At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Application (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Value Share, by Application (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure North America At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Europe At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure APAC At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Production, Import, Consumption and Export (2017-2022)

    • Table North America At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table North America At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure North America At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table North America At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table North America At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure North America At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure United States At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure United States At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Canada At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Canada At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Mexico At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Table Europe At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table Europe At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Europe At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Europe At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table Europe At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Europe At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Germany At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Germany At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure UK At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure UK At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure France At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure France At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Italy At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Italy At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Spain At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Spain At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Belgium At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Poland At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Poland At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Russia At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Russia At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Turkey At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Table APAC At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table APAC At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure APAC At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table APAC At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table APAC At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure APAC At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Japan At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Japan At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure India At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure India At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Korea At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Brazil At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Africa At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Figure Argentina At-Home Drug of Abuse (DOA) Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina At-Home Drug of Abuse (DOA) Testing Sales Value and Growth Rate (2017-2028)

    • Table UCP Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table UCP Biosciences Product Profiles, Application and Specification

    • Table UCP Biosciences At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Orient New Life Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orient New Life Medical Product Profiles, Application and Specification

    • Table Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Express Diagnostics Int’l Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Express Diagnostics Int’l Product Profiles, Application and Specification

    • Table Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Assure Tech (Hangzhou) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Assure Tech (Hangzhou) Product Profiles, Application and Specification

    • Table Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Psychemedics Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Psychemedics Corporation Product Profiles, Application and Specification

    • Table Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Confirm BioSciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Confirm BioSciences Product Profiles, Application and Specification

    • Table Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Phamatech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Phamatech Product Profiles, Application and Specification

    • Table Phamatech At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quest Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quest Products Product Profiles, Application and Specification

    • Table Quest Products At-Home Drug of Abuse (DOA) Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US